DXC Technology Co stock: AI push with ServiceNow amid undervalued shares

DXC Technology's new multi-year ServiceNow partnership positions it as Customer Zero for agentic AI, potentially streamlining operations as shares trade below analyst targets. For investors eyeing IT services value plays, this signals modernization efforts in a competitive landscape. ISIN: US2538681030

You're eyeing DXC Technology Co stock because it's trading at levels that scream potential value in the IT services space. With shares around recent lows and a fresh multi-year partnership with ServiceNow announced in early April 2026, DXC is betting big on agentic AI to transform its operations and client offerings. This move comes as the company, listed on NYSE under ticker DXC in USD, navigates a challenging market, but positions it for efficiency gains that could appeal to global investors seeking turnaround stories.

As of: 09.04.2026

By Elena Voss, Senior Tech Equity Editor: DXC Technology leads in enterprise IT services, now leveraging AI partnerships to reshape its global business model amid sector shifts.

DXC Technology's Core Business and Strategic Pivot

DXC Technology Co, headquartered in Tysons Corner, Virginia, stands as a global powerhouse in IT services and solutions, serving enterprises across industries with mission-critical technology. You know the drill: in a world where businesses rely on seamless digital operations, DXC handles everything from cloud migration to cybersecurity and application services. The company's evolution from legacy IT outsourcing to modern AI-infused services reflects broader industry demands for agility and innovation.

This strategic pivot gained momentum with the early April 2026 announcement of a multi-year agreement with ServiceNow, where DXC acts as "Customer Zero" for the Core Business Suite. That means DXC deploys agentic AI—think autonomous agents handling complex tasks—across its Global Business Services to modernize multivendor operations. For you as an investor, this isn't just hype; it's DXC using itself as a live lab to build scalable blueprints for clients, potentially cutting costs and boosting margins over time.

Why does this matter right now? DXC's shares have lagged, down significantly over recent years, but this internal transformation could unlock efficiencies in a sector where margins are razor-thin. If executed well, you'll see DXC not only streamlining its own house but packaging those wins for revenue-generating client deals. Keep watching how quickly this rolls out across DXC's 100+ global locations serving Fortune 1000 clients.

Recent AI Initiatives Driving Momentum

On April 9, 2026, DXC launched Assure Smart Apps, built on ServiceNow, targeting insurers' claims, customer service, and underwriting processes. These apps promise to slash manual work by 30-40% without overhauling core systems, a huge draw for clients wary of big-bang transformations. You can imagine the appeal: insurers get AI-powered speedups with a 12-week rollout, letting DXC tap into a lucrative vertical.

This builds directly on the ServiceNow partnership, where DXC's early adoption creates real-world proof points. Shares may be hovering near lows, but these moves show proactive adaptation to AI trends dominating tech services. For U.S., European, or global investors, it's a reminder that DXC isn't standing still—it's embedding AI to stay competitive against pure-play cloud giants.

What should you watch? Deployment metrics from these apps and how they convert into multi-year contracts. If DXC delivers quantifiable ROI for insurers, it could spark a ripple effect across its portfolio, lifting revenue visibility.

Financial Snapshot and Valuation Appeal

DXC Technology trades on the NYSE in USD, with a market cap around $2.43 billion and a P/E ratio of 6.58, far below market averages, signaling potential undervaluation. Consensus analyst price targets hover around $15.60, implying upside from recent levels near $13.56, though ratings lean toward Hold or Reduce with no Buys noted. Earnings growth projections show a slight dip to $3.31 per share, but the low multiple factors in transformation risks already.

You'll appreciate the balance sheet resilience, including a $3.0 billion revolving credit facility renewed in early April 2026, providing liquidity for AI investments. Revenue dipped 2.4% year-over-year in the last reported quarter, yet EPS beat estimates at $0.68, showing operational discipline. Compared to peers like Globant or ASGN facing similar pressures, DXC's small daily moves suggest stock-specific dynamics rather than sector-wide woes.

For wealth builders, this setup screams "watch for entry": trading 60% below some fair value estimates, with AI catalysts in play. But execution is key—monitor quarterly updates for AI contribution to top-line growth. Globally, currency-neutral contracts shield DXC from forex volatility, a plus for international portfolios.

Analyst Views on DXC Technology

Analysts from major firms view DXC Technology with a cautious but opportunistic lens, assigning a consensus Reduce rating based on 5 Holds and 2 Sells, with an average score of 1.71 out of 5. The $15.60 price target reflects about 15% upside potential from recent prices around $13.56, driven by hopes for AI efficiencies offsetting earnings contraction forecasts of -1.19%. Coverage has been light, with only 4 reports in the past 90 days, indicating limited conviction but room for upgrades if partnerships deliver.

You won't find unanimous bulls here—concerns over multi-year share declines (32% YTD, 49% over 3 years) temper enthusiasm. Yet, sources highlight DXC's undervaluation, trading 60.9% below estimated fair value per some models, making it a contrarian pick. Reputable trackers like MarketBeat aggregate these views, emphasizing the need for AI execution to shift sentiment. Overall, analysts urge patience, watching for proof that ServiceNow integration boosts margins and client wins.

Investor Relevance in a Global Context

Whether you're building wealth in the U.S., Europe, or beyond, DXC Technology offers exposure to resilient IT services demand from enterprises digitizing amid economic uncertainty. With operations spanning continents, DXC's revenue is geographically diversified, reducing single-market risks for your portfolio. The AI pivot aligns with megatrends like automation, where insurers and others seek partners like DXC to avoid vendor lock-in.

Right now, relevance spikes because shares lag peers despite strategic moves—perfect for value hunters tolerant of turnaround timelines. You get dividend potential (though yield is N/A currently) and buyback flexibility in a low-P/E name. For younger investors, it's a lesson in sector rotation: IT services rebound when cloud hype cools, positioning DXC for catch-up gains.

Global angle? DXC's multivendor expertise suits hybrid environments common in Europe and Asia, where regulations favor flexible providers. Track client wins in these apps; they could validate long-term compounding for your holdings.

Risks and Key Questions Ahead

No stock is without hurdles, and DXC's include execution risk on AI rollouts—forecasts predict earnings declines if adoption lags. Competition from hyperscalers like AWS or Accenture intensifies pressure on margins, especially if clients consolidate vendors. Shares' 52-week range from $12.24 to $24.83 underscores volatility, amplified by past revenue softness.

Open questions loom: Will ServiceNow's agentic AI deliver 30-40% efficiency in practice, or face integration snags? How does DXC convert internal use into client revenue amid softer software demand?. Macro headwinds like interest rates could squeeze IT budgets, delaying deals.

As an investor, prioritize upcoming earnings on May 13, 2026, for AI metrics and guidance. Watch peer performance— if Globant or WNS falter less, DXC's lag may persist. Mitigate by sizing positions small, diversifying across tech services.

Should You Buy DXC Technology Now?

Buying DXC stock now hinges on your risk appetite for AI-driven turnarounds in IT services. If you believe in the ServiceNow partnership yielding efficiencies and new revenue streams, the undervalued P/E and analyst upside make a compelling case. But with Reduce consensus and earnings headwinds, it's not a slam-dunk—better as a watchlist name until Q1 results prove traction.

For U.S. investors, NYSE liquidity suits active trading; Europeans get currency exposure via USD; globals benefit from diversification. Next catalysts: May earnings, AI client announcements, margin readouts. DYOR, but DXC's story has legs if execution clicks.

Disclaimer: Not investment advice. Stocks are volatile financial instruments.